SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000831547-20-000005
Filing Date
2020-02-27
Accepted
2020-02-27 16:04:15
Documents
16
Period of Report
2020-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k20191231earningsre.htm   iXBRL 8-K 42028
2 EXHIBIT 99.1 exhibit991q42019.htm EX-99.1 260782
8 logo2013spectruma22.jpg GRAPHIC 25852
  Complete submission text file 0000831547-20-000005.txt   504186

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sppi-20200227.xsd EX-101.SCH 4576
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sppi-20200227_cal.xml EX-101.CAL 616
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sppi-20200227_def.xml EX-101.DEF 1466
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sppi-20200227_lab.xml EX-101.LAB 27263
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sppi-20200227_pre.xml EX-101.PRE 14106
10 EXTRACTED XBRL INSTANCE DOCUMENT a8-k20191231earningsre_htm.xml XML 4507
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35006 | Film No.: 20661899
SIC: 2834 Pharmaceutical Preparations